Protein expression in the livers and urinary bladders of hamsters exposed to sodium arsenite

Annals of the New York Academy of Sciences

Volumn 1140, Issue , 2008, Pages 325-334

  Chowdhury, Uttam K ^a   Aposhian, H Vasken ^a  

^a University of Arizona   (United States)

Author keywords

Arsenite; Bladder; Differential in gel electrophoresis; Fluorescence; Hamster; Liver; Protein expression

Indexed keywords

ARSENITE SODIUM; DYE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BLADDER; COMPUTER PROGRAM; CONFERENCE PAPER; CONTROLLED STUDY; FLUORESCENCE; HAMSTER; LIVER; MALE; MASS SPECTROMETRY; NONHUMAN; PROTEIN EXPRESSION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

CRICETINAE;

EID: 54949091893     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1454.019     Document Type: Conference Paper

References (25)

1. National Research Council. 2001. Arsenic in Drinking Water. Update to the 1999 Arsenic in Drinking Water Report. Washington, DC : National Academy Press.
2. Hopenhayn-Rich, C., M.L. Biggs, A. Fuchs, et al. 1996. Bladder cancer mortality with arsenic in drinking water in Argentina. Epidemiology 7 : 117 124.
3. Chen, C.J., C.W. Chen, M.M. Wu, et al. 1992. Cancer potential in liver, lung, bladder, and kidney due to ingested inorganic arsenic in drinking water. Br. J. Cancer 66 : 888 892.
4. International Agency for Research on Cancer. 1987. In IARC Monograph on the Evaluation of Carcinogenicity Risk to Humans. Overall Evaluation of Carcinogenicity: An Update of IARC Monographs 1-42 (Suppl. 7). Lyon, France : International Agency for Research on Cancer, pp. 100 106.
5. Rossman, T.G., A.N. Uddin & F.J. Burns. 2004. Evidence that arsenite acts as a cocarcinogen in skin cancer. Toxicol. Appl. Pharmacol. 198 : 394 404.
6. Smith, A.H., C. Hopenhayn-Rich, M.N. Bates, et al. 1992. Cancer risks from arsenic in drinking water. Environ. Health Perspect. 97 : 259 267.
7. Aposhian, H.V. & M.M. Aposhian. 2006. Arsenic toxicology: five questions. Chem. Res. Toxicol. 19 : 1 15.
8. Goering, P.L., H.V. Aposhian, M.J. Mass, et al. 1999. The enigma of arsenic carcinogenesis: role of metabolism. Toxicol. Sci. 49 : 5 14.
9. Waalkes, M.P., J. Liu, J.M. Ward, et al. 2004 Mechanisms underlying arsenic carcinogenesis: hypersensitivity of mice exposed to inorganic arsenic during gestation. Toxicology 198 : 31 38.
10. Aposhian, H.V., E.S. Gurzau, X.C. Le, et al. 2000. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem. Res. Toxicol. 13 : 693 697.
11. Del Razo, L.M., M. Styblo, W.R. Cullen, et al. 2001. Determination of trivalent methylated arsenicals in biological matrices. Toxicol. Appl. Pharmacol. 174 : 282 293.
12. Styblo, M., Z. Drobna, I. Jaspers, et al. 2002. The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ. Health Perspect. 5 : 767 771.
13. Chowdhury, U.K., R.A. Zakharyan, A. Hernandez, et al. 2006. Glutathione-S-transferase-omega [MMA(V) reductase] knockout mice: enzyme and arsenic species concentrations in tissues after arsenate administration. Toxicol. Appl. Pharmaol. 216 : 446 457.
14. Kitchin, K.T. 2001. Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 172 : 249 261.
15. Yamanaka, K., M. Hoshino, M. Okanoto, et al. 1990. Induction of DNA damage by dimethylarsine, a metabolite of inorganic arsenics, is for the major part likely due to its peroxyl radical. Biochem. Biophys. Res. Commun. 168 : 58 64.
16. Yamanaka, K. & S. Okada. 1994. Induction of lung-specific DNA damage by metabolically methylated arsenics via the production of free radicals. Environ. Health Perspect. 102 : 37 40.
17. Li, J.H. & T.G. Rossman. 1989. Mechanism of co-mutagenesis of sodium arsenite with N-methyl-N-nitrosourea. Biol. Trace Elem. 21 : 373 381.
18. Zhao, C.Q., M.R. Young, B.A. Diwan, et al. 1997. Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression. Proc. Natl. Acad. Sci. USA 94 : 10907 10912.
19. Abernathy, C.O., Y.P. Lui, D. Longfellow, et al. 1999. Arsenic: health effects, mechanisms of actions and research issues. Environ. Health Perspect. 107 : 593 597.
20. Unlu, M., M.E. Morgan & J.S. Minden. 1997. Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 18 : 2071 2077.
21. Tonge, R., J. Shaw, B. Middleton, et al. 2001. Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 1 : 377 396.
22. Gorg, A. 2004. Handbook: 2-D Electrophoresis Principles and Method, 3rd ed. Buckinghamshire, UK : Amersham Biosciences UK.
23. Zhou, G., H. Li, D. DeCamp, et al. 2002. 2D Differential in gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol. Cell Proteomics 1 : 117 123.
24. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 : 248 254.
25. Lopez, M.F., K. Berggren, E. Chernokalskaya, et al. 2000. A comparison of silver stain and SYPRO Ruby Protein Gel Stain with respect to protein detection in two-dimensional gels and identification by peptide mass profiling. Electrophoresis 21 : 3673 3683.